Potiga

Potiga is a brand name of ezogabine, approved by the FDA in the following formulation(s):

POTIGA (ezogabine - tablet; oral)

• 
  Manufacturer: VALEANT PHARMS
  
  Approval date: June 10, 2011
  
  Strength(s): 200MG, 300MG, 400MG ^[RLD], 50MG
  

Has a generic version of Potiga been approved?

No. There is currently no therapeutically equivalent version of Potiga available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Potiga. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Potiga.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • June 10, 2016 - NEW CHEMICAL ENTITY
  
  

See also...

• Potiga Consumer Information (Drugs.com)
• Potiga Consumer Information (Cerner Multum)
• Ezogabine Consumer Information (Cerner Multum)